{"id":"https://openalex.org/W2020228477","doi":"https://doi.org/10.1159/000065713","title":"Neoadjuvant Chemotherapy with Sequential Methotrexate and 5-Fluorouracil Scheduling, Epirubicin and Cisplatin for Locally Advanced Bladder Cancer","display_name":"Neoadjuvant Chemotherapy with Sequential Methotrexate and 5-Fluorouracil Scheduling, Epirubicin and Cisplatin for Locally Advanced Bladder Cancer","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2020228477","doi":"https://doi.org/10.1159/000065713","mag":"2020228477","pmid":"https://pubmed.ncbi.nlm.nih.gov/12187064"},"language":"en","primary_location":{"id":"doi:10.1159/000065713","doi":"https://doi.org/10.1159/000065713","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000065713","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5057732232","display_name":"Tsutomu Nishiyama","orcid":"https://orcid.org/0000-0002-5684-8364","observed_orcids":["https://orcid.org/0000-0002-5684-8364"]},"institutions":[{"id":"https://openalex.org/I4405256033","display_name":"Nagaoka Chuo General hospital","ror":"https://ror.org/03pgfk695","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4405256033"]},{"id":"https://openalex.org/I71395657","display_name":"Niigata University","ror":"https://ror.org/04ww21r56","country_code":"JP","type":"education","lineage":["https://openalex.org/I71395657"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tsutomu Nishiyama","raw_affiliation_strings":["Department of Urology, Niigata University School of Medicine, Niigata, Japan. nkh@niigata-inet.or.jp","Department of Urology, Koseiren Nagaoka Chuo General Hospital, Nagaoka, Japan","Department of Urology, Niigata University School of Medicine, Niigata, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Niigata University School of Medicine, Niigata, Japan. nkh@niigata-inet.or.jp","institution_ids":["https://openalex.org/I71395657"]},{"raw_affiliation_string":"Department of Urology, Koseiren Nagaoka Chuo General Hospital, Nagaoka, Japan","institution_ids":["https://openalex.org/I4405256033"]},{"raw_affiliation_string":"Department of Urology, Niigata University School of Medicine, Niigata, and","institution_ids":["https://openalex.org/I71395657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108944892","display_name":"Toshiki Tanikawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71395657","display_name":"Niigata University","ror":"https://ror.org/04ww21r56","country_code":"JP","type":"education","lineage":["https://openalex.org/I71395657"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshiki Tanikawa","raw_affiliation_strings":["Department of Urology, Niigata University School of Medicine, Niigata, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Niigata University School of Medicine, Niigata, and","institution_ids":["https://openalex.org/I71395657"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007596741","display_name":"Yoshihiko Tomita","orcid":"https://orcid.org/0000-0002-7465-9591","observed_orcids":["https://orcid.org/0000-0002-7465-9591"]},"institutions":[{"id":"https://openalex.org/I71395657","display_name":"Niigata University","ror":"https://ror.org/04ww21r56","country_code":"JP","type":"education","lineage":["https://openalex.org/I71395657"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshihiko Tomita","raw_affiliation_strings":["Department of Urology, Niigata University School of Medicine, Niigata, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Niigata University School of Medicine, Niigata, and","institution_ids":["https://openalex.org/I71395657"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5041873070","display_name":"Kota Takahasi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I71395657","display_name":"Niigata University","ror":"https://ror.org/04ww21r56","country_code":"JP","type":"education","lineage":["https://openalex.org/I71395657"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kota Takahasi","raw_affiliation_strings":["Department of Urology, Niigata University School of Medicine, Niigata, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology, Niigata University School of Medicine, Niigata, and","institution_ids":["https://openalex.org/I71395657"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1032,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.77612739,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"63","issue":"1","first_page":"1","last_page":"5"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12695","display_name":"Urinary and Genital Oncology Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.8889999985694885},{"id":"https://openalex.org/keywords/locally-advanced-bladder-cancer","display_name":"locally advanced bladder cancer","score":0.968999981880188},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8980000019073486},{"id":"https://openalex.org/keywords/methotrexate","display_name":"methotrexate","score":0.8529999852180481},{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9929999709129333},{"id":"https://openalex.org/keywords/epirubicin","display_name":"epirubicin","score":0.902999997138977},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":1.0},{"id":"https://openalex.org/keywords/bladder-preservation","display_name":"bladder preservation","score":0.843999981880188},{"id":"https://openalex.org/keywords/cystectomy","display_name":"cystectomy","score":0.7860000133514404},{"id":"https://openalex.org/keywords/myelosuppression","display_name":"myelosuppression","score":0.7950000166893005},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.4440000057220459}],"concepts":[{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.815725564956665},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7660894393920898},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6561717391014099},{"id":"https://openalex.org/C2781059491","wikidata":"https://www.wikidata.org/wiki/Q422232","display_name":"Methotrexate","level":2,"score":0.6264040470123291},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.6201636791229248},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.5984636545181274},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5715847015380859},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.5573237538337708},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5233739614486694},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5193951725959778},{"id":"https://openalex.org/C2777132456","wikidata":"https://www.wikidata.org/wiki/Q282629","display_name":"Vinblastine","level":3,"score":0.5119761228561401},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4821564555168152},{"id":"https://openalex.org/C2778397455","wikidata":"https://www.wikidata.org/wiki/Q50429865","display_name":"Antimetabolite","level":3,"score":0.44509491324424744},{"id":"https://openalex.org/C2778065480","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Transitional cell carcinoma","level":4,"score":0.44237300753593445},{"id":"https://openalex.org/C2775910329","wikidata":"https://www.wikidata.org/wiki/Q245995","display_name":"Cystectomy","level":4,"score":0.4421078860759735},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.42793524265289307},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2792150378227234},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.12048739194869995},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.08783313632011414}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008727","descriptor_name":"Methotrexate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017024","descriptor_name":"Chemotherapy, Adjuvant","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000065713","doi":"https://doi.org/10.1159/000065713","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000065713","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},{"id":"pmid:12187064","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12187064","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":18,"referenced_works":["https://openalex.org/W1893740135","https://openalex.org/W1932620090","https://openalex.org/W1941332786","https://openalex.org/W1968487988","https://openalex.org/W1983410186","https://openalex.org/W1987702547","https://openalex.org/W2001746159","https://openalex.org/W2042471859","https://openalex.org/W2051381106","https://openalex.org/W2053188628","https://openalex.org/W2054341710","https://openalex.org/W2127572941","https://openalex.org/W2331751210","https://openalex.org/W2398683549","https://openalex.org/W2415307606","https://openalex.org/W2467198999","https://openalex.org/W2619733974","https://openalex.org/W4238668552"],"related_works":["https://openalex.org/W2101070604","https://openalex.org/W2398683549","https://openalex.org/W2396846532","https://openalex.org/W1984431613","https://openalex.org/W2410167743","https://openalex.org/W2415307606","https://openalex.org/W2033211830","https://openalex.org/W1932620090","https://openalex.org/W2008346828","https://openalex.org/W1534334787"],"abstract_inverted_index":{"INTRODUCTION:":[0],"Transitional":[1],"cell":[2],"carcinoma":[3],"of":[4,62,112,132,137,150,162,197],"the":[5,13,39,113,125,151,163,167,171,195],"bladder":[6,89,143,172,200],"is":[7,158],"moderately":[8],"sensitive":[9],"to":[10,22,124,128],"chemotherapy.":[11],"Notably,":[12],"methotrexate,":[14],"doxorubicin,":[15],"vinblastine":[16],"and":[17,29,38,54,78,82,101,118,153,170],"cisplatin":[18,83],"regimen":[19,193],"was":[20,36,91,179],"found":[21],"produce":[23],"a":[24,30,63,67,94,129,203],"high":[25],"overall":[26],"response":[27,69,130],"rate":[28,131,165],"modest":[31],"survival":[32,164],"advantage.":[33],"However,":[34],"toxicity":[35,205],"significant":[37],"therapy":[40,126],"rarely":[41],"results":[42],"in":[43,60,93,106,194],"long-term":[44],"disease-free":[45],"survival.":[46],"In":[47],"several":[48],"clinical":[49],"series,":[50],"sequentially":[51],"delivered":[52],"methotrexate":[53,77],"5-fluorouracil":[55,79],"followed":[56],"by":[57],"leucovorin":[58],"rescue":[59],"expectation":[61],"biochemical":[64],"modulation":[65],"has":[66],"higher":[68],"rate.":[70],"METHODS:":[71],"The":[72],"combination":[73],"chemotherapy":[74],"using":[75],"sequential":[76],"scheduling,":[80],"epirubicin":[81],"(MFAP":[84],"regimen)":[85],"for":[86],"locally":[87,198],"advanced":[88,199],"cancer":[90,201],"evaluated":[92],"neoadjuvant":[95],"setting.":[96],"Thirty-seven":[97],"patients":[98,114,139],"(32":[99],"males":[100],"5":[102],"females)":[103],"were":[104],"enrolled":[105],"this":[107],"study.":[108],"RESULTS:":[109],"Six":[110],"(16.2%)":[111],"had":[115,121,145],"complete":[116],"responses":[117,123],"26":[119],"(70.3%)":[120],"partial":[122],"amounting":[127],"86.5%.":[133],"At":[134],"follow-up,":[135],"10":[136],"13":[138],"(76.9%)":[140],"who":[141],"underwent":[142],"preservation":[144,173],"not":[146],"developed":[147],"muscle-invasive":[148],"recurrence":[149],"disease":[152],"kept":[154],"their":[155],"bladder.":[156],"There":[157],"no":[159],"statistical":[160],"difference":[161],"between":[166],"cystectomy":[168],"group":[169,174],"(p":[175],"=":[176],"0.86).":[177],"Toxicity":[178],"relatively":[180],"mild":[181],"but":[182],"with":[183,202],"some":[184],"severe":[185],"myelotoxic":[186],"effects.":[187],"CONCLUSIONS:":[188],"MFAP":[189],"represents":[190],"an":[191],"active":[192],"treatment":[196],"moderate":[204],"profile.":[206]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2017,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}